Factors related to the discontinuation and mortality rates of a cardiac rehabilitation programme in patients with Chagas disease: a 6-year experience in a Brazilian tertiary centre.
Aged
Brazil
/ epidemiology
Cardiac Rehabilitation
/ mortality
Chagas Disease
/ classification
Female
Humans
Longitudinal Studies
Male
Middle Aged
Patient Dropouts
/ statistics & numerical data
Retrospective Studies
Severity of Illness Index
Socioeconomic Factors
Survival Analysis
Tertiary Care Centers
Chagas cardiomyopathy
Chagas disease
cardiac rehabilitation
exercise
heart failure
survival analysis
Journal
Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
pubmed:
12
12
2020
medline:
29
7
2021
entrez:
11
12
2020
Statut:
ppublish
Résumé
To describe the clinical and sociodemographic characteristics of participants as well as discontinuation and mortality rates in a cardiac rehabilitation programme (CRP) tailored to Chagas disease (CD). Participants underwent functional capacity, anthropometry and cardiac function evaluations before beginning a CRP. Univariate and multivariate Cox proportional hazards models were performed to investigate the associations between clinical and sociodemographic characteristics at baseline with discontinuation rates and deaths. Forty-two patients were enrolled in the CRP (61.9% men, mean age of 58.1 ± 11.8 years). During a median follow-up period of 10.8 months, 74% discontinued and 14% died while enrolled in CRP. 34% of the patients who discontinued CRP died during follow-up. White race (HR = 0.09; 95% CI 0.01-1.00), right ventricular systolic dysfunction (HR = 10.54; 95% CI 1.24-89.50) and oxygen pulse (HR = 0.69; 95% CI 0.48-0.99) were independently associated with death while enrolled in CRP. Married status (HR = 0.44; 95% CI 0.21-0.95) was independently associated with discontinuation rates from CRP. VO In this population, sociodemographic aspects and severity of CD were important determinants of CRP discontinuation and mortality. Décrire les caractéristiques cliniques et sociodémographiques des participants ainsi que les taux d'abandon et de décès dans un programme de réadaptation cardiaque (PRC) adapté à la maladie de Chagas (MC). MÉTHODES: Les participants ont subi des évaluations de la capacité fonctionnelle, de l'anthropométrie et de la fonction cardiaque avant de commencer un PRC. Des modèles de risques proportionnels de Cox univariés et multivariés ont été appliqués pour étudier les associations entre les caractéristiques cliniques et sociodémographiques au départ avec les taux d'abandon et les décès. RÉSULTATS: 42 patients ont été enrôlés dans le PRC (61,9% d'hommes, âge moyen de 58,1 ± 11,8 ans). Au cours d'une période médiane de suivi de 10,8 mois, 74% ont abandonné et 14% sont décédés durant leur enrôlement au PRC. 34% des patients qui ont arrêté le PRC sont décédés au cours du suivi. La race blanche (HR = 0,09; IC95%: 0,01-1,00), le dysfonctionnement systolique ventriculaire droite (HR = 10,54; IC95%: 1,24-89,50) et le pouls d'oxygène (HR = 0,69; IC95%: 0,48-0,99) étaient indépendamment associés avec le décès lors de l’enrôlement au PRC. Le statut marié (HR = 0,44; IC95%: 0,21-0,95) était indépendamment associé aux taux d'abandon de la CRP. Le pic de VO2 (HR = 0,85; IC95%: 0,74-0,98) et l'arrêt du PRC pour des raisons liées à la MC (HR = 8,33; IC95%: 1,91 à 36,27) étaient les variables indépendamment associées au décès après l'arrêt du PRC. Dans cette population, les aspects sociodémographiques et la sévérité de la MC étaient des déterminants importants de l'arrêt du PRC et du décès.
Autres résumés
Type: Publisher
(fre)
Décrire les caractéristiques cliniques et sociodémographiques des participants ainsi que les taux d'abandon et de décès dans un programme de réadaptation cardiaque (PRC) adapté à la maladie de Chagas (MC). MÉTHODES: Les participants ont subi des évaluations de la capacité fonctionnelle, de l'anthropométrie et de la fonction cardiaque avant de commencer un PRC. Des modèles de risques proportionnels de Cox univariés et multivariés ont été appliqués pour étudier les associations entre les caractéristiques cliniques et sociodémographiques au départ avec les taux d'abandon et les décès. RÉSULTATS: 42 patients ont été enrôlés dans le PRC (61,9% d'hommes, âge moyen de 58,1 ± 11,8 ans). Au cours d'une période médiane de suivi de 10,8 mois, 74% ont abandonné et 14% sont décédés durant leur enrôlement au PRC. 34% des patients qui ont arrêté le PRC sont décédés au cours du suivi. La race blanche (HR = 0,09; IC95%: 0,01-1,00), le dysfonctionnement systolique ventriculaire droite (HR = 10,54; IC95%: 1,24-89,50) et le pouls d'oxygène (HR = 0,69; IC95%: 0,48-0,99) étaient indépendamment associés avec le décès lors de l’enrôlement au PRC. Le statut marié (HR = 0,44; IC95%: 0,21-0,95) était indépendamment associé aux taux d'abandon de la CRP. Le pic de VO2 (HR = 0,85; IC95%: 0,74-0,98) et l'arrêt du PRC pour des raisons liées à la MC (HR = 8,33; IC95%: 1,91 à 36,27) étaient les variables indépendamment associées au décès après l'arrêt du PRC.
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
355-365Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
World Health Organization. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 2015: 90: 33-43.
Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 2010: 115: 14-21.
Rassi A, Rassi A, Rezende JM. American Trypanosomiasis (Chagas Disease). Infect Dis Clin North Am 2012: 26: 275-291.
Bocchi EA. Exercise training in Chagas' cardiomyopathy: trials are welcome for this neglected heart disease. Eur J Heart Fail 2010: 12: 782-784.
Mendes FSNS, Mediano MFF, Souza FCC et al. Effect of physical exercise training in patients with chagas heart disease (from the PEACH STUDY). Am J Cardiol 2020: 125: 1413-1420.
Flynn KE, Piña IL, Whellan DJ et al. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009: 301: 1451.
O’Connor CM, Whellan DJ, Lee KL et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009: 301: 1439.
Sagar VA, Davies EJ, Briscoe S et al. Exercise-based rehabilitation for heart failure: systematic review and meta-analysis. Open Heart 2015: 2: e000163.
Lima MMO, Rocha MOC, Nunes MCP et al. A randomized trial of the effects of exercise training in Chagas cardiomyopathy. Eur J Heart Fail 2010: 12: 866-873.
Mediano MFF, de Mendes FSNS, Pinto VLM et al. Cardiac rehabilitation program in patients with Chagas heart failure: a single-arm pilot study. Rev Soc Bras Med Trop 2016: 49: 319-328.
Mediano MFF, de Mendes FSNS, Pinto VLM, Silva PS, Hasslocher-Moreno AM, Sousa AS. Reassessment of quality of life domains in patients with compensated Chagas heart failure after participating in a cardiac rehabilitation program. Rev Soc Bras Med Trop 2017: 50: 404-407.
Barbour KA, Miller NH. Adherence to exercise training in heart failure: a review. Heart Fail Rev 2008: 13: 81-89.
Conraads VM, Deaton C, Piotrowicz E et al. Adherence of heart failure patients to exercise: barriers and possible solutions: A position statement of the Study Group on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2012: 14: 451-458.
Dias JCP, Ramos AN, Gontijo ED et al. Brazilian Consensus on Chagas Disease, 2015. Epidemiol Serv Saude 2016: 25: 1-10.
Lapa JS, Saraiva RM, Hasslocher-Moreno AM et al. Dealing with initial inconclusive serological results for chronic Chagas disease in clinical practice. Eur J Clin Microbiol Infect Dis 2012: 31: 965-974.
Herdy A, López-Jiménez F, Terzic C et al. South American Guidelines for Cardiovascular Disease Prevention and Rehabilitation. Arq Bras Cardiol 2014: 103: 1-31.
Hellerstein H, Franklin B. Rehabilitation of Coronary Patient. John Wiley: New York, 1978.
Mendes FSNS, Sousa AS, Souza FCCC et al. Effect of physical exercise training in patients with Chagas heart disease: study protocol for a randomized controlled trial (PEACH study). Trials 2016: 17: 433.
Balady GJ, Arena R, Sietsema K et al. Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010: 122: 191-225.
Lohman TG, Roche AF, Martorel R. Anthropometric Standardization Reference Manual. Human Kinetics: Champaign, Illinois, 1988.
Lang RM, Badano LP, Mor-Avi V et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015: 28(1-39): e14.
World Health Organization (ed.), Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. WHO: Geneva, 2000.
Instituto Brasileiro de Geografia e Estatística (ed.), Pesquisa Nacional por Amostra de Domicílios. Pesquisa Especial de Tabagismo-PETab. IBGE: Rio de Janeiro, 2009.
Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 1981: 64: 1227-1234.
Grande D, Gioia M, Terlizzese P, Iacoviello M. Heart Failure and Kidney Disease. In: Islam M (ed.), Heart Failure: From Research to Clinical Practice. Springer: Cham, 2017, 219-238.
Nesello PFT, Tairova O, Tairova M et al. Treatment of the aged patients at a large cardiac rehabilitation center in the Southern Brazil and some aspects of their dropout from the therapeutic programs. Open Access Maced J Med Sci 2016: 4: 654.
Wittmer M, Volpatti M, Piazzalonga S, Hoffmann A. Expectation, satisfaction, and predictors of dropout in cardiac rehabilitation. Eur J Prev Cardiolog 2012: 19: 1082-1088.
Turk-Adawi KI, Grace SL. Narrative review comparing the benefits of and participation in cardiac rehabilitation in high-, middle- and low-income countries. Heart Lung Circ 2015: 24: 510-520.
DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004: 23: 207-218.
Levy RL. Social support and compliance: a selective review and critique of treatment integrity and outcome measurement. Soc Sci Med 1983: 17: 1329-1338.
Pardaens S, De Smedt D, De Bacquer D, Willems A, Verstreken S, De Sutter J. Comorbidities and psychosocial characteristics as determinants of dropout in outpatient cardiac rehabilitation. J Cardiovasc Nurs 2017: 32: 14-21.
Resurrección DM, Moreno-Peral P, Gómez-Herranz M et al. Factors associated with non-participation in and dropout from cardiac rehabilitation programmes: a systematic review of prospective cohort studies. Eur J Cardiovasc Nurs 2019: 18: 38-47.
French DP, Lewin RJP, Watson N, Thompson DR. Do illness perceptions predict attendance at cardiac rehabilitation and quality of life following myocardial infarction? J Psychosom Res 2005: 59: 315-322.
Kaplan RM, Simon HJ. Compliance in medical care: reconsideration of self-predictions. Ann Behav Med 1990: 12: 66-71.
Albaz R. Factors affecting patient compliance in Saudi Arabia. J Social Sci 1997: 25: 5-8.
Fialho PH, Tura BR, Sousa AS et al. Effects of an exercise program on the functional capacity of patients with chronic Chagas’ heart disease, evaluated by cardiopulmonary testing. Rev Soc Bras Med Trop 2012: 45: 220-224.
Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011: 8: 30-41.
Ni H, Xu J. Recent trends in heart failure-related mortality: United States, 2000-2014. NCHS Data Brief 2015: 231: 1-8.
Bocchi EA, Bestetti RB, Scanavacca MI, Cunha Neto E, Issa VS. Chronic CHAGAS heart disease management. J Am Coll Cardiol 2017: 70: 1510-1524.
Chor D, Pereira A, Pacheco AG et al. Context-dependence of race self-classification: results from a highly mixed and unequal middle-income country. PLoS One 2019: 14: e0216653.
Giolo SR, Soler JMP, Greenway SC et al. Brazilian urban population genetic structure reveals a high degree of admixture. Eur J Hum Genet 2012: 20: 111-116.
Mersha TB, Abebe T. Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities. Hum Genomics 2015: 9: 1.
Nascimento CA, Gomes VA, Silva SK et al. Left atrial and left ventricular diastolic function in chronic Chagas disease. J Am Soc Echocardiogr 2013: 26: 1424-1433.
De Groote P, Millaire A, Foucher-Hossein C et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998: 32: 948-954.
Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995: 25: 1143-1153.
Nunes MCP, Rocha MOC, Ribeiro ALP et al. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas’ cardiomyopathy. Int J Cardiol 2008: 127: 372-379.
Nunes MCP, Beloti FR, Lima MMO et al. Functional capacity and right ventricular function in patients with Chagas heart disease. Eur J Echocardiogr 2010: 11: 590-595.
Souza FCC, De Lorenzo A, Serra SM, Colafranceschi AS. Chagas’ cardiomyopathy prognosis assessment through cardiopulmonary exercise testing. Int J Cardiovasc Sci 2015: 28: 440-450.
Ritt LE, Carvalho AC, Feitosa GS et al. Heart failure survival score in patients with Chagas disease: correlation with functional variables. Rev Esp Cardiol 2012: 65: 538-543.
Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 1982: 65: 1213-1223.
Mady C, Cardoso RH, Barretto AC, Da Luz PL, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas’ cardiomyopathy. Circulation 1994: 90: 3098-3102.
Ritt LE, Carvalho AC, Feitosa GS et al. Cardiopulmonary exercise and 6-min walk tests as predictors of quality of life and long-term mortality among patients with heart failure due to Chagas disease. Int J Cardiol 2013: 168: 4584-4585.
Taylor C, Tsakirides C, Moxon J et al. Exercise dose and all-cause mortality within extended cardiac rehabilitation: a cohort study. Open Heart 2017: 4: e000623.
Corvera-Tindel T, Doering LV, Gomez T, Dracup K. Predictors of noncompliance to exercise training in heart failure. J Cardiovasc Nurs 2004: 19: 269-277.